MBTPS1 and subarachnoid hemorrhage: Of note, fingolimod treatment was shown to lead to an obvious amelioration of brain tissue loss in both intracerebral hemorrhage and subarachnoid hemorrhage models and patients through reducing lymphocytic inflammation, preserving the blood–brain barrier, and limiting brain edema by functional activation of S1P signaling (24, 27, 28).